The Service of the Commission for the Protection of Competition received on behalf of the company Galderma Pharma SA, notification of a proposed concentration according to Article 13 of the Control of Concentrations between Enterprises Law (Number 22(I)/99), concerning a cash offer by Galderma Pharma SA to the shareholders of Q-Med AB to tender all of its shares.
Galderma Pharma SA is a joint venture between Nestle και L΄Oreal S.A. and is active in the research, development and marketing of products for therapeutic and other purposes for the skin, hair and nails.
Q-Med AB is a public company whose shares are tradable in the stock market of NASDAQ, OMX Stockholm and Nordic List. Mid. Cap. Q-Med AB is active in the production and sale of high quality medical products.